EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Modulation of immunity by the secreted phospholipase A 2 family

Makoto Murakami iD, Hiroyasu Sato, Yoshitaka Taketomi

Immunological Reviews · 2023-08 · 317 (1) · 42-70

DOI: 10.1111/imr.13205 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 10.04.2023. Verfasst von Makoto Murakami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The …. Hauptthemen laut MEDLINE: Phospholipases A2, Secretory. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the phospholipase A 2 (PLA 2 ) superfamily, which typically catalyzes the sn ‐2 hydrolysis of phospholipids to yield fatty acids and lysophospholipids, the secreted PLA 2 (sPLA 2 ) family contains 11 isoforms in mammals. Individual sPLA 2 s have unique enzymatic specificity toward fatty acids and polar heads of phospholipid substrates and display distinct tissue/cellular distributions, suggesting their distinct physiological functions. Recent studies using knockout and/or transgenic mice for a full set of sPLA 2 s have revealed their roles in modulation of immunity and related disorders. Application of mass spectrometric lipidomics to these mice has enabled to identify target substrates and products of individual sPLA 2 s in given tissue microenvironments. sPLA 2 s hydrolyze not only phospholipids in the plasma membrane of activated, damaged or dying mammalian cells, but also extracellular phospholipids such as those in extracellular vesicles, microbe membranes, lipoproteins, surfactants, and dietary phospholipids, thereby exacerbating or ameliorating various diseases. The actions of sPLA 2 s are dependent on, or independent of, the generation of fatty acid‐ or lysophospholipid‐derived lipid mediators according to the pathophysiological contexts. In this review, we make an overview of our current understanding of the roles of individual sPLA 2 s in various immune responses and associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phospholipases A2, SecretoryAnimalsHumansMiceFatty AcidsMice, TransgenicCell MembraneMammals

Stichwörter der Autor:innen

inflammationlipid mediatormembranemetabolismphospholipase A2phospholipid

Substanzen

Phospholipases A2, SecretoryFatty Acids

Autor:innen und Institutionen

  • Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan.

ORCID-Profile: Makoto Murakami

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Murakami, M., Sato, H., & Taketomi, Y. (2023). Modulation of immunity by the secreted phospholipase A 2 family. Immunological Reviews, 317(1), 42-70. https://doi.org/10.1111/imr.13205

Vancouver

Murakami M, Sato H, Taketomi Y. Modulation of immunity by the secreted phospholipase A 2 family. Immunological Reviews. 2023;317(1):42-70. doi:10.1111/imr.13205

BibTeX
@article{Murakami2023,
  author = {Murakami, Makoto and Sato, Hiroyasu and Taketomi, Yoshitaka},
  title = {Modulation of immunity by the secreted phospholipase A 2 family},
  journal = {Immunological Reviews},
  year = {2023},
  volume = {317},
  number = {1},
  pages = {42--70},
  doi = {10.1111/imr.13205}
}
Kostenlos starten →